HomeCompareSEBYY vs JNJ

SEBYY vs JNJ: Dividend Comparison 2026

SEBYY yields 5.85% · JNJ yields 2.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 SEBYY wins by $15159.24M in total portfolio value
10 years
SEBYY
SEBYY
● Live price
5.85%
Share price
$5.47
Annual div
$0.32
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$15159.27M
Annual income
$14,677,063,049.08
Full SEBYY calculator →
JNJ
Johnson & Johnson
● Live price
2.13%
Share price
$244.44
Annual div
$5.20
5Y div CAGR
28%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.3K
Annual income
$4,689.40
Full JNJ calculator →

Portfolio growth — SEBYY vs JNJ

📍 SEBYY pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodSEBYYJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, SEBYY + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
SEBYY pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SEBYY
Annual income on $10K today (after 15% tax)
$497.01/yr
After 10yr DRIP, annual income (after tax)
$12,475,503,591.72/yr
JNJ
Annual income on $10K today (after 15% tax)
$180.82/yr
After 10yr DRIP, annual income (after tax)
$3,985.99/yr
At 15% tax rate, SEBYY beats the other by $12,475,499,605.73/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SEBYY + JNJ for your $10,000?

SEBYY: 50%JNJ: 50%
100% JNJ50/50100% SEBYY
Portfolio after 10yr
$7579.65M
Annual income
$7,338,533,869.24/yr
Blended yield
96.82%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

SEBYY
No analyst data
Altman Z
2.5
Piotroski
7/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
-6.4% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SEBYY buys
0
JNJ buys
8
PoliticianChamberTickerTypeAmountDate
Thomas H. Kean🏢 House$JNJ▼ Sell$15,001 - $50,0002026-01-23
Julie Johnson🏢 House$JNJ▼ Sell$1,001 - $15,0002025-12-18
Lloyd Doggett🏢 House$JNJ▲ Buy$1,001 - $15,0002025-12-09
Thomas H. Kean🏢 House$JNJ▼ Sell$15,001 - $50,0002025-11-20
Julie Johnson🏢 House$JNJ▼ Sell$1,001 - $15,0002025-11-13
Rich McCormick🏢 House$JNJ▲ Buy$1,001 - $15,0002025-11-05
Ro Khanna🏢 House$JNJ▲ Buy$1,001 - $15,0002025-10-30
Ro Khanna🏢 House$JNJ▲ Buy$1,001 - $15,0002025-10-30
Ro Khanna🏢 House$JNJ▲ Buy$1,001 - $15,0002025-10-30
Jared Moskowitz🏢 House$JNJ▼ Sell$1,001 - $15,0002025-10-10
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricSEBYYJNJ
Forward yield5.85%2.13%
Annual dividend / share$0.32$5.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%28%
Portfolio after 10y$15159.27M$30.3K
Annual income after 10y$14,677,063,049.08$4,689.40
Total dividends collected$15125.80M$15.4K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: SEBYY vs JNJ ($10,000, DRIP)

YearSEBYY PortfolioSEBYY Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$11,869$1,169.43$10,592$272.30+$1.3KSEBYY
2$15,295$2,594.49$11,289$357.73+$4.0KSEBYY
3$22,614$6,249.01$12,123$472.89+$10.5KSEBYY
4$41,468$17,270.29$13,141$629.86+$28.3KSEBYY
5$103,563$59,193.03$14,408$846.81+$89.2KSEBYY
6$387,134$276,320.58$16,021$1,151.60+$371.1KSEBYY
7$2,344,927$1,930,694.33$18,122$1,588.22+$2.33MSEBYY
8$24,367,974$21,858,901.56$20,930$2,228.20+$24.35MSEBYY
9$450,658,692$424,584,960.27$24,792$3,191.91+$450.63MSEBYY
10$15,159,267,850$14,677,063,049.08$30,274$4,689.40+$15159.24MSEBYY

SEBYY vs JNJ: Complete Analysis 2026

SEBYYStock

SEB SA designs, manufactures, and markets small household appliances worldwide. It provides electrical cooking, food preparation, and beverage preparation products, including electrical cooking products comprising deep fryers, rice cookers, electric pressure cookers, informal meal appliances, waffle makers, grills, toasters, multicookers, coffee makers, espresso machines, electric kettles, home beer-taps, soy-milk makers, blenders, cooking food processors, kitchen machines, mixers, beaters, etc. The company also offers linen, home, and personal care products, such as irons and steam generators, garment steamers, canister vacuum cleaners with or without dust bag, steam and upright vacuum cleaners, vacuum weepers, versatile vacuums, robots, fans, heaters, air treatment appliances, hair care appliances, depilators, electrical beard trimmers, hair clippers, and bathroom scales. In addition, it provides cookware products, such as frying pans, saucepans pots, pressure cookers, bakeware, kitchen utensils, food storage containers, vacuum flasks, thermo mugs, cutlery, and other products. Further, the company offers hotel equipment, crepe and waffle makers, planchas, and grills for professionals. It provides its products under various brands that primarily include Calor, Rowenta, Moulinex, Seb, Tefal, Krups, Lagostina, WMF, Schaerer, Wilbur Curtis, Hepp, Krampouz, Arno, Supor, Imusa, All-Clad, and Silit. The company was founded in 1857 and is headquartered in Écully, France.

Full SEBYY Calculator →

JNJHealthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →
📬

Get this SEBYY vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SEBYY vs SCHDSEBYY vs JEPISEBYY vs OSEBYY vs KOSEBYY vs MAINSEBYY vs ABBVSEBYY vs MRKSEBYY vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.